Pre-vaccination inflammation and B-cell signalling predict age-related hyporesponse to hepatitis B vaccination

[1]  F. Rodríguez-Frías,et al.  Immunogenicity of hepatitis B vaccine in patients with inflammatory bowel disease and the benefits of revaccination , 2015, Journal of gastroenterology and hepatology.

[2]  J. Praestgaard,et al.  mTOR inhibition improves immune function in the elderly , 2014, Science Translational Medicine.

[3]  Yuri Kotliarov,et al.  Global Analyses of Human Immune Variation Reveal Baseline Predictors of Postvaccination Responses , 2014, Cell.

[4]  Pablo Tamayo,et al.  Gene signatures related to B‐cell proliferation predict influenza vaccine‐induced antibody response , 2014, European journal of immunology.

[5]  E. van Anken,et al.  Missing Links in Antibody Assembly Control , 2013, International journal of cell biology.

[6]  Mark M. Davis,et al.  Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination , 2013, Proceedings of the National Academy of Sciences.

[7]  R. Janssen,et al.  Immunogenicity and safety of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in patients with chronic kidney disease. , 2013, Vaccine.

[8]  Ruth R. Montgomery,et al.  Age-dependent dysregulation of innate immunity , 2013, Nature Reviews Immunology.

[9]  C. Weyand,et al.  Understanding immunosenescence to improve responses to vaccines , 2013, Nature Immunology.

[10]  Kelly Domico,et al.  Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines. , 2013, Immunity.

[11]  T. Miyakawa,et al.  Genomic responses in mouse models poorly mimic human inflammatory diseases , 2013 .

[12]  R. Gamelli,et al.  Genomic responses in mouse models poorly mimic human inflammatory diseases , 2013, Proceedings of the National Academy of Sciences.

[13]  Larissa B. Thackray,et al.  IRF-3, IRF-5, and IRF-7 Coordinately Regulate the Type I IFN Response in Myeloid Dendritic Cells Downstream of MAVS Signaling , 2013, PLoS pathogens.

[14]  R. Gorczynski.  CD200:CD200R-Mediated Regulation of Immunity , 2012 .

[15]  Kim-Anh Lê Cao,et al.  A novel approach for biomarker selection and the integration of repeated measures experiments from two assays , 2012, BMC Bioinformatics.

[16]  Katsuaki Sato,et al.  Plasmacytoid dendritic cells are crucial for the initiation of inflammation and T cell immunity in vivo. , 2011, Immunity.

[17]  Gary D Bader,et al.  Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and Interpretation , 2010, PloS one.

[18]  R. Effros,et al.  Sustained CD28 Expression Delays Multiple Features of Replicative Senescence in Human CD8 T Lymphocytes , 2010, Journal of Clinical Immunology.

[19]  Ruth R. Montgomery,et al.  Human innate immunosenescence: causes and consequences for immunity in old age. , 2009, Trends in immunology.

[20]  J. Hiscott,et al.  Transcriptional re‐programming of primary macrophages reveals distinct apoptotic and anti‐tumoral functions of IRF‐3 and IRF‐7 , 2009, European journal of immunology.

[21]  Bastian R. Angermann,et al.  Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses , 2008, The Journal of experimental medicine.

[22]  J. Schultze,et al.  T cell responses to hepatitis B surface antigen are detectable in non-vaccinated individuals. , 2008, World journal of gastroenterology.

[23]  L. Almasy,et al.  Discovery of expression QTLs using large-scale transcriptional profiling in human lymphocytes , 2007, Nature Genetics.

[24]  J. Davis.  Bioinformatics and Computational Biology Solutions Using R and Bioconductor , 2007 .

[25]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[26]  M. Feldmann,et al.  T-cell-mediated signalling in immune, inflammatory and angiogenic processes: the cascade of events leading to inflammatory diseases. , 2004, Current drug targets. Inflammation and allergy.

[27]  M. Teitell.  OCA-B regulation of B-cell development and function. , 2003, Trends in immunology.

[28]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[29]  C. Freitag,et al.  Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins , 2002, The Lancet.

[30]  Benjamin Schwartz,et al.  General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP). , 2002, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[31]  H. Clevers,et al.  The β-catenin–TCF-1 pathway ensures CD4+CD8+ thymocyte survival , 2001, Nature Immunology.

[32]  W. Wachsman,et al.  Repression of IL-2 Promoter Activity by the Novel Basic Leucine Zipper p21SNFT Protein1 2 , 2000, The Journal of Immunology.

[33]  Mathewson,et al.  Serum and Intestinal Antitoxin Antibody Responses after Immunization with the Whole-Cell/Recombinant B Subunit (WC/rBS) Oral Cholera Vaccine in North American and Mexican Volunteers. , 1996, Journal of travel medicine.

[34]  M. Clements,et al.  Effect of age on the immunogenicity of yeast recombinant hepatitis B vaccines containing surface antigen (S) or PreS2 + S antigens. , 1994, The Journal of infectious diseases.

[35]  E. Schiff,et al.  Immunogenicity of two recombinant hepatitis B vaccines in older individuals. , 1993, The American journal of medicine.

[36]  K. Rajewsky,et al.  Persistence of memory B cells in mice deprived of T cell help. , 1990, International immunology.

[37]  G. Glass,et al.  Some characteristics of the human erythrocyte as a function of donor and cell age. , 1985, Experimental hematology.

[38]  M. Levine,et al.  Serologic differentiation between antitoxin responses to infection with Vibrio cholerae and enterotoxin-producing Escherichia coli. , 1983, The Journal of infectious diseases.

[39]  Maqc Consortium.  The MicroArray Quality Control ( MAQC )-II study of common practices for the development and validation of microarray-based predictive models , 2012 .

[40]  Shuzhao Li,et al.  Systems vaccinology: Probing humanity’s diverse immune systems with vaccines , 2014, Proceedings of the National Academy of Sciences.

[41]  Eva K. Lee,et al.  Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans , 2009, Nature Immunology.

[42]  P. Mahadevan,et al.  An overview , 2007, Journal of Biosciences.

[43]  H Clevers,et al.  The beta-catenin--TCF-1 pathway ensures CD4(+)CD8(+) thymocyte survival. , 2001, Nature immunology.

[44]  Trevor Hastie,et al.  Imputing Missing Data for Gene Expression Arrays , 2001 .

[45]  R. Tibshirani,et al.  Estimating the number of clusters in a data set via the gap statistic , 2000 .

[46]  P. van Damme,et al.  The first combined vaccine against hepatitis A and B: an overview. , 1999, Vaccine.

[47]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[48]  Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). , 1991, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[49]  J. Phair,et al.  Ageing and infection. , 1988, Ciba Foundation symposium.

[50]  Sandra Romero-Steiner,et al.  Molecular signatures of antibody responses derived from a systems biology study of five human vaccines , 2022 .